Current Status
Not Enrolled
Price
Free
Get Started
Course
Slides
Information

Treating MPS I

Program: Mucopolysaccharidosis I
To obtain CME/CE credit, you must LOG-IN and ENROLL (click orange button at top of page)

Provided by

Support for this activity has been made possible through an educational grant from Sanofi Genzyme

Release date: 08/26/20
Expiration date: 08/31/21
Estimated time to complete: 0.25 hours

Activity Description

Without treatment, the prognosis for individuals with Mucopolysaccharidosis I (MPS I), especially the more severe form of the disease, is discouraging. Early access to treatment is also important in order to reduce disease damage and progression. In this module, our faculty educator will explore strategies for treating MPS I.

Activity Faculty

Paul Orchard, MD
Medical Director
Inherited Metabolic and Storage Disease Program
Professor of Pediatrics
Division of Blood and Marrow Transplantation
University of Minnesota Medical School

Target Audience

This activity has been designed to meet the educational needs of physicians and nursing professionals who may be involved in the care of patients with MPS I. Other members of the care team may also participate.

Learning Objectives

After participating in the activity, learners should be better able to:

  • Identify the treatment options available for MPS I and the importance of early access to treatment to reduce disease damage/progression

Accreditation and Credit Designation

In support of improving patient care, American Academy of CME, Inc. is Jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians
American Academy of CME, Inc., designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse Practitioners and Nurses
American Academy of CME, Inc., designates this educational activity for 0.25 ANCC contact hours.

Other members of the care team will receive a certificate of participation.

Disclosure Statement

According to the disclosure policy of the Academy, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relevant relationships with any commercial interests related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity and levels of evidence. Disclosures are as follows:

Dr. Orchard has the following relationships to disclose:

  • Advisory Board: Orchard Therapeutics, Bluebird Bio
  • Consultant: Immusoft, Orchard Therapeutics, Sanofi, Avrobio
  • Grant/Research Support: Magenta, Immusoft, Sanofi

Planners for this activity have no relevant financial relationships with any commercial interests.

This activity will review off-label or investigational information.

The opinions expressed in this educational activity are those of the faculty, and do not represent those of the Academy or CheckRare. This activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically and draw conclusions only after careful consideration of all available scientific information.

Method of Participation

There are no fees to participate in the activity. Participants must review the activity information including the learning objectives and disclosure statements, as well as the content of the activity. To receive CME credit for your participation, please complete the post-program assessment. Your certificate can be mailed to you in approximately 30 days.

Hardware/Software Requirements

Windows Requirements: • Operating system: Windows XP Service Pack 2 or later • Browser: Internet Explorer 7 or later, Mozilla Firefox 2.5 or later • Internet connection: DSL, cable modem, or other high-speed connection

Macintosh Requirements: • Operating system: Mac OS X v10.3 or later • Browser: Mozilla Firefox 2.5 or later • Internet connection: DSL, cable modem, or other high-speed connection

Privacy

For more information about the American Academy of CME privacy policy, please access http://www.academycme.org/privacy.htm. For more information about CheckRare’s privacy policy, please access https://checkrare.com/privacy/

Contact

For any questions, please contact: CEServices@academycme.org

Copyright

© 2020. This CME-certified activity is held as copyrighted © by American Academy of CME and CheckRare CE. Through this notice, the Academy and CheckRare grant permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).

Treating MPS I

Program: Mucopolysaccharidosis I

Download all of the slides for this activity

Treating MPS I

Program: Mucopolysaccharidosis I

Provided by

Support for this activity has been made possible through an educational grant from Sanofi Genzyme

Release date: 08/26/20
Expiration date: 08/31/21
Estimated time to complete: 0.25 hours

Activity Description

Without treatment, the prognosis for individuals with Mucopolysaccharidosis I (MPS I), especially the more severe form of the disease, is discouraging. Early access to treatment is also important in order to reduce disease damage and progression. In this module, our faculty educator will explore strategies for treating MPS I.

Activity Faculty

Paul Orchard, MD
Medical Director
Inherited Metabolic and Storage Disease Program
Professor of Pediatrics
Division of Blood and Marrow Transplantation
University of Minnesota Medical School

Target Audience

This activity has been designed to meet the educational needs of physicians and nursing professionals who may be involved in the care of patients with MPS I. Other members of the care team may also participate.

Learning Objectives

After participating in the activity, learners should be better able to:

  • Identify the treatment options available for MPS I and the importance of early access to treatment to reduce disease damage/progression

Accreditation and Credit Designation

In support of improving patient care, American Academy of CME, Inc. is Jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians
American Academy of CME, Inc., designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse Practitioners and Nurses
American Academy of CME, Inc., designates this educational activity for 0.25 ANCC contact hours.

Other members of the care team will receive a certificate of participation.

Disclosure Statement

According to the disclosure policy of the Academy, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relevant relationships with any commercial interests related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity and levels of evidence. Disclosures are as follows:

Dr. Orchard has the following relationships to disclose:

  • Advisory Board: Orchard Therapeutics, Bluebird Bio
  • Consultant: Immusoft, Orchard Therapeutics, Sanofi, Avrobio
  • Grant/Research Support: Magenta, Immusoft, Sanofi

Planners for this activity have no relevant financial relationships with any commercial interests.

This activity will review off-label or investigational information.

The opinions expressed in this educational activity are those of the faculty, and do not represent those of the Academy or CheckRare. This activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically and draw conclusions only after careful consideration of all available scientific information.

Method of Participation

There are no fees to participate in the activity. Participants must review the activity information including the learning objectives and disclosure statements, as well as the content of the activity. To receive CME credit for your participation, please complete the post-program assessment. Your certificate can be mailed to you in approximately 30 days.

Hardware/Software Requirements

Windows Requirements: • Operating system: Windows XP Service Pack 2 or later • Browser: Internet Explorer 7 or later, Mozilla Firefox 2.5 or later • Internet connection: DSL, cable modem, or other high-speed connection

Macintosh Requirements: • Operating system: Mac OS X v10.3 or later • Browser: Mozilla Firefox 2.5 or later • Internet connection: DSL, cable modem, or other high-speed connection

Privacy

For more information about the American Academy of CME privacy policy, please access http://www.academycme.org/privacy.htm. For more information about CheckRare's privacy policy, please access https://checkrare.com/privacy/

Contact

For any questions, please contact: CEServices@academycme.org

Copyright

© 2020. This CME-certified activity is held as copyrighted © by American Academy of CME and CheckRare CE. Through this notice, the Academy and CheckRare grant permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).

  • Sign up
Lost your password? Please enter your username or email address. You will receive a link to create a new password via email.
We do not share your personal details with anyone.